Screener
Corcept Therapeutics CORT Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Corcept Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
FAQ
- What is Corcept Therapeutics's price / sales?
- Corcept Therapeutics (CORT) reported price / sales of 11.2× in Q2 2026.
- How has Corcept Therapeutics's price / sales changed year-over-year?
- Corcept Therapeutics's price / sales decreased by 1.2% year-over-year, from 11.4× to 11.2×.
- What is the long-term trend for Corcept Therapeutics's price / sales?
- Over 5 years (2020 to 2025), Corcept Therapeutics's price / sales has grown at a -10.8% compound annual growth rate (CAGR), from 8.5× to 4.8×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Corcept Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude